نتایج جستجو برای: like tyrosine kinase 3

تعداد نتایج: 2524300  

Journal: :Critical reviews in oncology/hematology 2007
Kathrin T Doepfner Danielle Boller Alexandre Arcaro

Acute myeloid leukemia (AML) is a quickly progressing, heterogeneous clonal disorder of hematopoietic progenitor cells. Significant progress in understanding the pathogenesis of AML has been achieved in the past few years. Two major types of genetic events are thought to give rise to leukemic transformation: alterations in the activity of transcription factors controlling hematopoietic differen...

2015
Alexa S. Green Thiago T. Maciel Marie-Anne Hospital Chae Yin Fetta Mazed Elizabeth C. Townsend Sylvain Pilorge Mireille Lambert Etienne Paubelle Arnaud Jacquel Florence Zylbersztejn Justine Decroocq Laury Poulain Pierre Sujobert Nathalie Jacque Kevin Adam Jason C. C. So Olivier Kosmider Patrick Auberger Olivier Hermine David M. Weinstock Catherine Lacombe Patrick Mayeux Gary J. Vanasse Anskar Y. Leung Ivan C. Moura Didier Bouscary Jerome Tamburini

Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) is frequently detected in acute myeloid leukemia (AML) patients and is associated with a dismal long-term prognosis. FLT3 tyrosine kinase inhibitors provide short-term disease control, but relapse invariably occurs within months. Pim protein kinases are oncogenic FLT3-ITD targets expressed in AML cells. We show that increased Pim...

2011
Amanda Parmar Stefanie Marz Sally Rushton Christina Holzwarth Katarina Lind

Targeting constitutively activated FMS-like tyrosine kinase 3 [(FLT3); FLT3-ITD] with tyrosine kinase inhibitor (TKI) in acute myeloid leukemia (AML) leads to clearance of blasts in the periphery but not in the bone marrow, suggesting a protective effect of the marrow niche on leukemic stem cells. In this study, we examined the effect of stromal niche cells on CD34þ progenitors from patients wi...

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2012

Journal: :Cancer research 2009
Nikolas von Bubnoff Richard A Engh Espen Aberg Jana Sänger Christian Peschel Justus Duyster

FMS-like tyrosine kinase 3 (FLT3) inhibitors have shown activity in the treatment of acute myelogenous leukemia (AML). Secondary mutations in target kinases can cause clinical resistance to therapeutic kinase inhibition. We have previously shown that sensitivity toward tyrosine kinase inhibitors varies between different activating FLT3 mutations. We therefore intended to determine whether diffe...

Journal: :Cancer research 2011
Amanda Parmar Stefanie Marz Sally Rushton Christina Holzwarth Katarina Lind Sabine Kayser Konstanze Döhner Christian Peschel Robert A J Oostendorp Katharina S Götze

Targeting constitutively activated FMS-like tyrosine kinase 3 [(FLT3); FLT3-ITD] with tyrosine kinase inhibitor (TKI) in acute myeloid leukemia (AML) leads to clearance of blasts in the periphery but not in the bone marrow, suggesting a protective effect of the marrow niche on leukemic stem cells. In this study, we examined the effect of stromal niche cells on CD34(+) progenitors from patients ...

Journal: :Molecular pathology : MP 2002
D A Buckley G Loughran G Murphy C Fennelly R O'Connor

AIMS To study the regulation of type 1 insulin like growth factor receptor (IGF-1R) tyrosine kinase activity using the fission yeast Schizosaccharomyces pombe and a green fluorescent protein (GFP) tagged, full length IGF-1R. METHODS The beta chain of the IGF-1R (betawt) was expressed under inducible conditions in the fission yeast S. pombe. Western blot analysis with antiphosphotyrosine antib...

Journal: :Cancer research 2011
Sebastian Kreiter Mustafa Diken Abderraouf Selmi Jan Diekmann Sebastian Attig Yves Hüsemann Michael Koslowski Christoph Huber Özlem Türeci Ugur Sahin

Intranodal immunization with antigen-encoding naked RNA may offer a simple and safe approach to induce antitumor immunity. RNA taken up by nodal dendritic cells (DC) coactivates toll-like receptor (TLR) signaling that will prime and expand antigen-specific T cells. In this study, we show that RNA vaccination can be optimized by coadministration of the DC-activating Fms-like tyrosine kinase 3 (F...

Journal: :The Biochemical journal 2000
M Ariga T Nedachi M Akahori H Sakamoto Y Ito F Hakuno S Takahashi

We have reported that pretreatment of rat FRTL-5 thyroid cells with thyrotropin (TSH) markedly potentiates the mitogenic response to insulin-like growth factor-I (IGF-I). The present study was undertaken to determine whether the augmentation by cAMP of IGF-I-dependent tyrosine phosphorylation of known IGF-I receptor substrates plays an important role in the cAMP-dependent potentiation of DNA sy...

Journal: :Endocrinology 1998
B Kim P S Leventhal M F White E L Feldman

Insulin-like growth factor I (IGF-I) is a potent neurotropic factor promoting the differentiation and survival of neuronal cells. SH-SY5Y human neuroblastoma cells are a well characterized in vitro model of nervous system growth. We report here that IGF-I stimulated the tyrosine phosphorylation of the type I IGF receptor (IGF-IR) and insulin receptor substrate-2 (IRS-2) in a time- and concentra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید